Edwards Lifesciences Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
Edwards Lifesciences (EW) Tops Q3 EPS by 2c
October 24, 2017 4:18 PM EDTEdwards Lifesciences (NYSE: EW) reported Q3 EPS of $0.88, $0.02 better than the analyst estimate of $0.86. Revenue for the quarter came in at $821.5 million versus the consensus estimate of $831.98 million.
GUIDANCE:
Edwards Lifesciences sees Q4 2017 EPS of $0.84-$0.94, versus the consensus of $0.91.... More



